WASHINGTON – The Drug Enforcement Administration today announced proposed regulations to improve DEA’s ability to oversee the production of dangerous drugs at the height of the national opioid crisis. This proposed regulation would further limit excess quantities of medications that might be vulnerable to diversion for illicit distribution and use...

NEW YORK – On October 18, DEA Special Operations Division Special Agent in Charge Wendy C. Woolcock and U.S. Attorney for the Southern District of New York Geoffrey S. Berman announced that on a jury returned a guilty verdict against Juan Antonio Hernández Alvarado, aka “Tony Hernández,” on all four...

WASHINGTON – With robust public participation over the course of 17 prior events, the National Prescription Drug Take Back Day Initiative continues to remove ever-higher amounts of opioids and other medicines from the nation’s homes, where they are vulnerable to misuse, theft or abuse by family members and visitors, including...

WASHINGTON – Following the successful launch of the 2019 National Red Ribbon Campaign earlier this month with First Lady Melania Trump at the annual Red Ribbon Rally , DEA is encouraging communities nationwide to Go Red for Red Ribbon – an effort to continue the momentum and promote awareness of...

WASHINGTON – First Lady Melania Trump today joined DEA Acting Administrator Uttam Dhillon to celebrate the official launch of the 2019 Red Ribbon campaign, dedicated to preserving the memory of DEA Special Agent Enrique “Kiki” Camarena – a DEA special agent who was kidnapped, tortured, and murdered in Mexico by...

​ ​ PHILADELPHIA – Special Agent in Charge of the Drug Enforcement Administration’s Philadelphia Field Division Jonathan A. Wilson today announced today the release of the Drug-Related Overdose Deaths in Pennsylvania, 2018 report. For the third year in a row, the DEA Philadelphia Field Division has partnered with the University...

WASHINGTON – The U.S. Drug Enforcement Administration and the U.S. Food and Drug Administration have issued warning letters to four website owners of rogue online pharmacies offering to distribute or dispense controlled substances, including opioids, and advertising their sale in violation of federal law. This is the first time the...

WASHINGTON – In an effort to reduce the availability of deadly illegal fentanyl in America, the U.S. Drug Enforcement Administration has proposed to control three substances used by operators of clandestine laboratories to illicitly manufacture the deadly Schedule II controlled substance. Two Notices of Proposed Rulemaking were published in the...

WASHINGTON – The U.S. Drug Enforcement Administration is proposing to reduce the amount of five Schedule II opioid controlled substances that can be manufactured in the United States next year compared with 2019, per the Notice of Proposed Rulemaking being published in the Federal Register tomorrow and available for public...

WASHINGTON – The Drug Enforcement Administration today announced that it is moving forward to facilitate and expand scientific and medical research for marijuana in the United States. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. DEA anticipates that registering...